Pictet Asset Management Holding Sa Rhythm Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 329,339 shares of RYTM stock, worth $18.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
329,339
Previous 801,796
58.92%
Holding current value
$18.4 Million
Previous $32.9 Million
47.59%
% of portfolio
0.02%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding RYTM
# of Institutions
191Shares Held
67.3MCall Options Held
834KPut Options Held
78.6K-
Primecap Management CO Pasadena, CA7.22MShares$403 Million0.28% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$377 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$357 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$340 Million4.44% of portfolio
-
Goldman Sachs Group Inc New York, NY3.88MShares$217 Million0.03% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.11B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...